StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3029% above fair value
$520.66−15.79 (-2.94%)

Close on Nov 19, 2026Market cap $131.97BP/E 30.3Yield –

Vertex Pharmaceuticals Net product revenues — Total by Quarter

Net product revenues — Total ($M) ($M)

Vertex Pharmaceuticals Net product revenues — Total: $3,334M in Q2 2026, up 13.2% from a year earlier. That is the highest of the 34 quarters on record here.

Latest, Q2 2026
3,334
Period ended Jun 30, 2026
Change on a year earlier
+13.2%
2,944 in Q2 2025
History
34 quarters
Since Q1 2017
Sources
16
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Revenue Disaggregation Note & Form 8-K.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet product revenues — Total ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20263,334+13.2%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 20262,987+8.2%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 20253,190+9.5%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20253,076+11.0%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20252,944+11.3%Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 20252,760+2.6%Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 20242,912–Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20242,772–Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 20242,646–Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 20242,691–Form 10-Q (filed 2025-05-06) ↗
Q4 2022Dec 31, 20222,303+11.1%Form 10-K (filed 2024-02-15) ↗
Q3 2022Sep 30, 20222,334+17.7%Form 10-Q (filed 2022-10-28) ↗
Q2 2022Jun 30, 20222,196+22.5%Form 10-Q (filed 2022-08-05) ↗
Q1 2022Mar 31, 20222,098+21.7%Form 10-Q (filed 2022-05-06) ↗
Q4 2021Dec 31, 20212,073+27.4%Form 10-K (filed 2024-02-15) ↗
Q3 2021Sep 30, 20211,984+29.1%Form 10-Q (filed 2022-10-28) ↗

Breakdown

What makes up net product revenues — Total

Cite this data

StockData. (2026). Vertex Pharmaceuticals Net product revenues — Total ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-product-total

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?